Morning Trend | Can EVEREST MED trigger emotional recovery after panic selling and extreme overselling?

On December 29th, EVEREST MED experienced a significant decline, with the pharmaceutical sector negatively impacted by the medical insurance catalog, leading to intensified capital outflows. The lowest price approached 42.50 yuan, with massive trading volume accompanied by the release of panic sentiment. The technical indicators KDJ and RSI simultaneously showed extreme overselling, while the MACD death cross deepened. Major traders are closely observing the situation, and speculative funds have not yet seen a stop to the decline. There have been no significant positive developments in the industry recently, and there is an increasing tendency for risk aversion due to policy risks. After a large release of panic selling, it will be difficult to form an effective rebound in the short term without new positive news, and with repeated trading, the volatility of the market increases the uncertainty of short-term trading. Funds are rapidly changing hands, with major players choosing to wait and see. Future attention should be paid to policy trends and changes in trading volume, and caution is advised against the risk of a second sell-off if repair expectations fall short